[ad_1]
Researchers at the University of Colorado Anschutz Medical Campus have found a promising therapeutic candidate that may aid in the restoration of vision in people suffering from multiple sclerosis (MS) and other neurodegenerative diseases. Read this also Why is early detection of glaucoma important? Doctor points out warning signs to be careful about
The drug, LL-341070, improves the brain’s ability to repair damaged myelin – the protective sheath that surrounds nerve fibers. Myelin damage is a hallmark of disorders such as MS, as well as a common consequence of aging, and it often causes visual impairment, loss of motor abilities, and cognitive decline.
How this medicine can help restore vision:
Research focused on vision has shown that the brain has some ability to repair itself when myelin is damaged, but the process can be slow and inefficient. The researchers observed that LL-341070 significantly sped up the repair process and improved vision-related brain function in mice even after severe damage.
“This research brings us closer to a world where the brain has the ability to heal itself,” said Ethan Hughes, PhD, co-lead author and associate professor in the Department of Cell and Developmental Biology at the CU School of Medicine. “Using this ability, we hope to help people suffering from diseases like MS by potentially reversing some of the damage, giving people the opportunity to regain their vision and cognitive function.” Read this also From diabetes to cancer: How your eyes may reveal the first signs of serious health risks
The researchers found that the treatment made the repair process more effective after severe damage, highlighting the importance of intervention in cases of severe injury. Even partial repair of myelin was found to significantly improve visual brain functions.
“We’ve known for years that myelin plays an important role in brain function,” said Daniel Denman, PhD, assistant professor in the Department of Physiology and Biophysics at the CU School of Medicine and co-lead author of the study. “This study highlights the role of cortical myelin in visual function. The drug could be a game-changer because it accelerates the brain’s natural repair mechanisms.” Read this also Doctor shares common vision problems in children and ways to deal with them
Researchers plan to test the drug in other areas of the brain and refine the treatment, hoping to make it even more effective and eventually accessible to patients.
“This discovery is just the beginning,” Hughes said. “We are optimistic that LL-341070 and similar therapies may one day provide real, tangible benefits to patients by improving overall brain function and quality of life.”
Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always seek the advice of your doctor with any questions you may have about a medical condition.
[ad_2]
